Theralink Technologies, Inc. (THER)

Revenue by Segment

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Dec 31, 2019	Sep 30, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Biotechnology (Startups)	606.80K	567.91K	505.60K	181.23K	-
Biotechnology (Startups) Growth	6.85%	12.32%	178.99%	-	-
Total	606.80K	567.91K	505.60K	181.23K	-
Total Growth	6.85%	12.32%	178.99%	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error